3391N Stock Chart & Stats
$351.06
$0.00(0.00%)
At close: 4:00 PM EDT
$351.06
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$351.06 - $351.06
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
$114.18B
Enterprise Value$887.52K
Total Cash (Recent Filing)$202.13B
Total Debt (Recent Filing)$208.49B
Price to Earnings (P/E)18.2
Beta0.00
Next Earnings
Oct 07, 2026EPS Estimate
3.77Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)144.56
Shares Outstanding454,521,480
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio0.30
Price to Book (P/B)0.88
Price to Sales (P/S)0.53
P/FCF Ratio12.98
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$287.77Price Target Upside-18.03% Downside
Rating ConsensusModerate Buy
Number of Analyst Covering6
EPS Forecast (FY)10.87
Revenue Forecast (FY)$275.63B
Bulls Say, Bears Say
Bulls Say
Sustained Revenue GrowthMulti-year top-line expansion culminating in ~32% revenue growth in 2026 indicates durable demand and successful store/channel execution. Strong revenue momentum supports scale benefits, purchasing leverage, and room to invest in network expansion or higher-margin categories over the medium term.
Stable Gross MarginsA stable gross margin near 30% over multiple years signals resilient merchandise mix and pricing power in core drugstore categories. Consistent gross profitability provides a structural cushion to absorb SG&A or supply-cost variability while supporting long-term margin sustainability.
Improved Cash Generation In 2026A material improvement in operating and free cash flow in 2026, following a stronger 2025, indicates the business can convert revenue into cash when execution aligns. Enhanced cash generation supports reinvestment, debt servicing or shareholder returns and strengthens medium-term financial flexibility.
Bears Say
Weak Net Margin ConversionPersistent low-2% net margins and a decline in earnings even as revenue surged point to structural margin pressure or rising operating costs. Low bottom-line conversion limits retained earnings, constrains ROE improvement, and reduces the firm's ability to fund growth from internally generated profits.
Step-up In Debt And Lower ROEA sharp increase in debt in 2026 and a notable drop in ROE indicate deteriorating capital efficiency and higher financial leverage. Elevated debt raises interest and refinancing risk, reduces flexibility for investments, and magnifies downside if earnings do not recover sustainably.
Uneven Cash Flow HistoryMarked volatility in operating and free cash flow across years undermines predictability of internal funding for capex, dividends or debt repayment. Dependence on lumpy cash conversion increases execution risk and heightens sensitivity to adverse sales or cost shocks over the medium term.
TSURUHA Holdings News
3391N FAQ
What was TSURUHA Holdings Inc’s price range in the past 12 months?
TSURUHA Holdings Inc lowest stock price was $351.06 and its highest was $351.06 in the past 12 months.
What is TSURUHA Holdings Inc’s market cap?
TSURUHA Holdings Inc’s market cap is $114.18B.
When is TSURUHA Holdings Inc’s upcoming earnings report date?
TSURUHA Holdings Inc’s upcoming earnings report date is Oct 07, 2026 which is in 28 days.
How were TSURUHA Holdings Inc’s earnings last quarter?
TSURUHA Holdings Inc released its earnings results on Jul 08, 2026. The company reported $3.274 earnings per share for the quarter, beating the consensus estimate of $2.722 by $0.552.
Is TSURUHA Holdings Inc overvalued?
According to Wall Street analysts TSURUHA Holdings Inc’s price is currently Overvalued.
Does TSURUHA Holdings Inc pay dividends?
TSURUHA Holdings Inc does not currently pay dividends.
What is TSURUHA Holdings Inc’s EPS estimate?
TSURUHA Holdings Inc’s EPS estimate is 3.77.
How many shares outstanding does TSURUHA Holdings Inc have?
TSURUHA Holdings Inc has 454,521,480 shares outstanding.
What happened to TSURUHA Holdings Inc’s price movement after its last earnings report?
TSURUHA Holdings Inc reported an EPS of $3.274 in its last earnings report, beating expectations of $2.722. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of TSURUHA Holdings Inc?
Currently, no hedge funds are holding shares in MX:3391N
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
TSURUHA Holdings Inc
Tsuruha Holdings Inc. is a Japan-based drugstore holding company operating a nationwide chain of retail pharmacies. The company's stores sell pharmaceuticals, cosmetics, daily necessities, and food products, with additional operations in Thailand.
3391N Stock 12 Month Forecast
Average Price Target
$287.77
▼(-18.03% Downside)








